Archive

HIV Prevention in SA Needs Local Lenacapavir Manufacturing

HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.

Read More

Spar’s Pharmacy Expansion Targets Health-Conscious Shoppers

Spar Wellness Pharmacy Expansion taps into growing consumer demand for health and wellness, aiming to challenge Clicks and Dis-Chem.

Read More

SA’s Healthcare Austerity Crisis Threatens Specialist Training

SA’s healthcare austerity crisis erodes specialist training and public health capacity, risking rights to care and driving emigration.

Read More

2025 Health in Review: Challenges and Triumphs

Dive into the 2025 Health in Review, reflecting on South Africa’s healthcare struggles and clinical successes in HIV and TB treatment.

Read More

Treasury Threatens Health Departments with Takeover

National Treasury threatens health departments in Gauteng, KZN, the Free State, and the Northern Cape with administrative management.

Read More

1.4% SEP Increase Impacts Pharmaceutical Investment

Understanding the 1.4% SEP increase: why the pharmaceutical sector is urging a reconsideration of the price cap.

Read More

Medical Scheme Increases Amidst Regulatory Concerns

BHF highlights the unsustainability of current medical scheme increases. Learn about essential reforms needed for healthcare.

Read More

Wegovy Weight-Loss Pill Offers Injectables Alternative

Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.

Read More

CMS Industry Report 2024: Medical Schemes Face Financial Strain

The CMS Industry Report 2024 reveals a surge in healthcare costs and an ageing population, forcing a shift in medical scheme strategies.

Read More

Pandemic Preparedness and Prevention: South Africa’s New Shield

Discover how Pandemic Preparedness and Prevention efforts in South Africa aim to improve bio-surveillance and health security.

Read More

Generic Lenacapavir Manufacturing: SA’s Bold 2027 Strategy

South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.

Read More

Mediclinic Restructuring Deal: Remgro and MSC to Split Assets

Remgro and MSC announce a Mediclinic restructuring deal that splits Southern African and Swiss assets to streamline healthcare operations.

Read More